All for Joomla The Word of Web Design
18
August Monday

The Center for Molecular Immunology (CIM) is conducting two clinical trials—named CORVAXCIM and COREPOCIM—on COVID-19 convalescents, according to Sc.D. Mayra Ramos Suzarte, head of CIM’s clinical trials department, who explained that the first of these studies evaluates the safety and effects of the CIMAvax-EGF lung cancer vaccine in convalescents with respiratory disorders after infection by SARS-CoV-2.

At the Hermanos Ameijeiras Surgical Clinical Hospital in Havana, consultations began this Wednesday to classify patients with Alzheimer's disease for their subsequent inclusion in the Phase III clinical trial with the neuroprotective drug NeuralCIM (NeuroEPO).

The start-up in the Neonatology Unit of the Camilo Cienfuegos Provincial Hospital in Sancti Spiritus(central Cuba) of a state-of-the-art equipment to detect congenital heart disease in newborns is an important step in Cuba's strategy to further reduce the infant mortality rate per 1,000 live births.

Cuban ministry of public health ( MINSAP by its Spanish acronym)) reported today that a total of 9,974,887 people, equivalent to 90 % of the Cuban population, have completed the anti-COVID-19 vaccination program in the country, with the national immunogens Soberana 02, Soberana Plus and Abdala.

Cuban ministry of public health ( MINSAP by its Spanish acronym)) reported today that a total of 9,974,887 people, equivalent to 90 % of the Cuban population, have completed the anti-COVID-19 vaccination program in the country, with the national immunogens Soberana 02, Soberana Plus and Abdala.

Cuban President Miguel Díaz-Canel Bermúdez referred today on Twitter the levels of control over COVID-19 in the country, albeit he warned about both the increase of dengue cases nationwide and the need to tackle the causes of non-communicable diseases.

More Articles ...